(Q40332214)

19 September 2017

Epidermal growth factor receptor expression and activation in neuroendocrine tumours (English)

1 reference

19 September 2017

Shah T

1

1 reference

19 September 2017

Hochhauser D

2

1 reference

19 September 2017

Frow R

3

1 reference

19 September 2017

Quaglia A

4

1 reference

19 September 2017

Dhillon AP

5

1 reference

19 September 2017

Caplin ME

6

1 reference

19 September 2017

1 May 2006

1 reference

Journal of Neuroendocrinology

19 September 2017

1 reference

19 September 2017

18

1 reference

19 September 2017

355-360

1 reference

19 September 2017

5

1 reference

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

19 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Assembly and topogenesis of the spectrin-based membrane skeleton in erythroid development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

The epidermal growth factor receptor as a multifunctional allosteric protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Autocrine, paracrine and juxtacrine signaling by EGFR ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Dimerization of cell surface receptors in signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Growth factor signaling by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Triggering signaling cascades by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Cell signaling by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Modulation of DNA repair in vitro after treatment with chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib (ZD1839).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Endocrine tumors of the digestive tract and pancreas: histogenesis, diagnosis and molecular basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

An analysis of 8305 cases of carcinoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Expression of full-length polyglutamine-expanded Huntingtin disrupts growth factor receptor signaling in rat pheochromocytoma (PC12) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Assessing epidermal growth factor receptor expression in tumours: what is the value of current test methods?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

Lack of mutations in EGFR in gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01425.X

10.1111/J.1365-2826.2006.01425.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference